Filing Details
- Accession Number:
- 0001179110-18-006498
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-09 19:17:55
- Reporting Period:
- 2018-05-07
- Accepted Time:
- 2018-05-09 19:17:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1200493 | E Dorothy Puhy | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2018-05-07 | 13,500 | $9.99 | 46,668 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-07 | 1,229 | $345.10 | 45,439 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-07 | 1,664 | $346.20 | 43,775 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-07 | 3,012 | $347.07 | 40,763 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-07 | 1,500 | $348.07 | 39,263 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-07 | 4,195 | $349.07 | 35,068 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-07 | 700 | $349.98 | 34,368 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-07 | 900 | $351.06 | 33,468 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-07 | 300 | $351.97 | 33,168 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-11-09 | 11,335 | $0.00 | 21,833 | No | 5 | G | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2017-11-09 | 11,335 | $0.00 | 11,335 | No | 5 | G | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-05-07 | 13,500 | $0.00 | 13,500 | $9.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-08-10 | 2020-08-11 | No | 4 | M | Direct |
Footnotes
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- This option becomes exerciseable in full on the date set forth in Table II, Column 6.
- Exercise of stock options pursuant to reporting owner's 10b5-1 plan.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $344.5600 and $345.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $345.6500 and $346.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $346.6000 and $347.4600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $347.8400 and $348.4800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $348.5600 and $349.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $349.7900 and $350.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $350.9600 and $351.2300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust.
Billionaire Hedge Funds
